Funder
AbbVie
Activate
Alfresa Pharma
JMDC
Gilead Sciences
Nippon Kayaku
Eli Lilly Japan
Mochida Pharmaceutical Company
Janssen Pharmaceuticals
Pfizer
Takeda Pharmaceutical Company
Bristol-Myers Squibb
Google
EA Pharma Co., Ltd.
ZERIA Pharmaceutical
JIMRO
Kyorin Pharmaceutical
Japan Foundation for Applied Enzymology
Otsuka Holdings
Janssen Japan
Mitsubishi Tanabe Pharma Corporation
Sandoz
Celltrion Healthcare
Thai-Nichi Institute of Technology
Activaid
Ferring Pharmaceuticals
JMDC Inc.
Miyarisan Pharmaceutical
Prometheus
Sekisui Medical
Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Gottlieb C, Alpert S. Regional jejunitis. Am J Roentgenol. 1937;38:881–3.
2. Nomura Y, Moriichi K, Fujiya M, et al. The endoscopic findings of the upper gastrointestinal tract in patients with Crohn’s disease. Clin J Gastroenterol. 2017;10:289–96.
3. Wespi SP, Frei R, Sulz MC. A very rare cause of a relapsing para-oesophageal abscess. Case Rep Gastroenterol. 2016;19(10):132–8.
4. Wang W, Ni Y, Ke C, Cheng Q, et al. Isolated Crohn’s disease of the esophagus with esophago-mediastinal fistula formation. World J Surg Oncol. 2012;10:208.
5. Ayre K, Warren B, Jeffrey K, et al. The role of CMV in steroid-resistant ulcerative colitis: a systematic review. J Crohns Colitis. 2009;3:141–8.